Global business with 32 manufacturing plants and 7 R&D centres
Europe
We manufacture injectable medicines in Europe, supplying products to the US, the MENA, and Europe. We have high-quality manufacturing plants in Germany, Italy and Portugal.
Middle East and North Africa (MENA)
The region’s principal player, we create branded generic medicines and are a leading licensing partner. In MENA, we are one of the largest pharmaceutical companies and a ‘partner of choice’.
US
We are one of the top 2 manufacturers of generic injectable medicines in the US by volume (Source: IQVIA MAT through February 2022, generic injectable volumes by eaches, excluding branded generics). We have a strong presence in the non-injectables market.
Canada
We market a rapidly growing and diversified portfolio of Health Canada-approved pharmaceuticals, including injectable and ophthalmic prescription medicines.